CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Go back to CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 7.72 -0.07 (0.9%)
Previous Close $7.79    52 Week High $4.54 
Open $7.65    52 Week Low $1.15 
Day High $7.79    P/E N/A 
Day Low $7.62    EPS $-0.55 
Volume 1,806,489